SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.55-1.3%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: medsunman who wrote (30123)1/12/2000 5:43:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
medunman, Thanks for yet another comprehensive update. Did Robinson specifically talk about Targretin and B-cell lymphoma. As you know, this is a very large market, but I had not heard anything on the Targretin front there (I of course know about the government Phase II trial for ONTAK for NHL).

Are there ongoing NHL trials involving Targretin?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext